Prime Medicine

(NASDAQ) PRME

Current Price$3.21

Market Cap$579.57M

Since IPO (2022)-79%

5 YearN/A

1 Year+143%

1 Month-9%

Prime Medicine Financials at a Glance

Market Cap

$579.57M

Revenue (TTM)

$4.03M

Net Income (TTM)

$198.37M

EPS (TTM)

$-1.25

P/E Ratio

-2.56

Dividend

$0.00

Beta (Volatility)

1.94 (High)

Dividend

$0.00

Beta (Volatility)

1.94 (High)

Price

$3.21

Volume

2,446,467.639

Open

$3.21

Price

$3.21

Volume

2,446,467.639

Open

$3.21

Previous Close

$3.21

Daily Range

$3.08 - $3.40

52-Week Range

$1.11 - $6.94

Dividend

$0.00

Beta (Volatility)

1.94 (High)

Price

$3.21

Volume

2,446,467.639

Open

$3.21

Previous Close

$3.21

Daily Range

$3.08 - $3.40

52-Week Range

$1.11 - $6.94

PRME News

PRME Revenue Misses by 73%

Motley Fool Markets TeamAug 7, 2025

Person in a lab gazing into a microscope

Why Prime Medicine Stock Was Climbing Higher This Week

Eric VolkmanMar 20, 2025

Why Prime Medicine Stock Is Soaring Today

Johnny RiceMar 19, 2025

Two people seated at a lab desk featuring a PC screen and microscope

Page 1

PRME: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Prime Medicine

Industry

Biotechnology

Sector

Health Care

Employees

146

CEO

Allan Jacob Reine, MD

Website

www.primemedicine.com

Headquarters

Cambridge, MA 02139, US

PRME Financials

Key Financial Metrics (TTM)

Gross Margin

-11%

Operating Margin

-51%

Net Income Margin

-49%

Return on Equity

-216%

Return on Capital

-80%

Return on Assets

-67%

Earnings Yield

-39.06%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$579.57M

Shares Outstanding

180.55M

Volume

2.45M

Avg. Volume

2.38M

Financials (TTM)

Gross Profit

$2.69M

Operating Income

$208.35M

EBITDA

$195.76M

Operating Cash Flow

$162.56M

Capital Expenditure

$4.53M

Free Cash Flow

$167.09M

Cash & ST Invst.

$177.68M

Total Debt

$116.43M

Prime Medicine Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$856.00K

-41.1%

Gross Profit

$1.00M

-168.8%

Gross Margin

-1.17%

N/A

Market Cap

$579.57M

N/A

Market Cap/Employee

$2.71M

N/A

Employees

214

N/A

Net Income

$49.12M

+5.3%

EBITDA

$48.80M

+3.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$20.98M

-9.2%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$105.97M

-7.3%

Short Term Debt

$8.55M

+24.6%

Return on Assets

-67.31%

N/A

Return on Invested Capital

-79.95%

N/A

Free Cash Flow

$42.92M

+16.3%

Operating Cash Flow

$42.71M

+12.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PROKProKidney Corp.

PROKProKidney Corp.$1.86-1.06%

REPLReplimune Group, Inc.

REPLReplimune Group, Inc.$4.07+21.86%

KURAKura Oncology, Inc.

KURAKura Oncology, Inc.$9.42+1.07%

RZLTRezolute, Inc.

RZLTRezolute, Inc.$3.21+4.05%

SEPNSepterna, Inc.

SEPNSepterna, Inc.$23.87-0.46%

EYPTEyePoint Pharmaceuticals, Inc.

EYPTEyePoint Pharmaceuticals, Inc.$13.66+1.86%

BCAXBicara Therapeutics Inc. Common Stock

BCAXBicara Therapeutics Inc. Common Stock$22.58-2.21%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

IRENIren

IRENIren$61.20+0.08%

POETPoet Technologies

POETPoet Technologies$10.95+0.14%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

AMDAdvanced Micro Devices

AMDAdvanced Micro Devices$455.19+0.11%

Questions About PRME

What is the current price of Prime Medicine?

Prime Medicine is trading at $3.21 per share.

What is the 52-week range for Prime Medicine?

Over the past 52 weeks, Prime Medicine has traded between $1.11 and $6.94.

How much debt does Prime Medicine have?

As of the most recent reporting period, Prime Medicine reported total debt of $114.51M.

How much cash does Prime Medicine have on hand?

Prime Medicine reported $64.11M in cash and cash equivalents in its most recent financial results.

What is Prime Medicine’s dividend yield?

Prime Medicine does not currently have a dividend yield.

Prime Medicine

Prime Medicine Financials at a Glance

PRME News

PRME Revenue Misses by 73%

Why Prime Medicine Stock Was Climbing Higher This Week

Why Prime Medicine Stock Is Soaring Today

Why Prime Medicine Stock Soared Nearly 12% Higher on Monday

2 Growth Stocks That Could Make You Richer

2 Magnificent Growth Stocks With Room to Run

Better Growth Stock: Archer Aviation or Prime Medicine?

1 Cathie Wood Stock That Could Deliver Life-Changing Returns in 10 Years

PRME: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Prime Medicine

PRME Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Prime Medicine Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PRME

What is the current price of Prime Medicine?

What is the 52-week range for Prime Medicine?

How much debt does Prime Medicine have?

How much cash does Prime Medicine have on hand?

What is Prime Medicine’s dividend yield?

Premium Investing Services